This Project Grant award for $737,998.00, awarded by the Defense Health Agency under the Military Medical Research and Development (CFDA 12.420) federal grant program, will fund research by The University of Texas Southwestern Medical Center to target MNK signaling to prevent and reverse chronic pain caused by complex traumatic injury. The research aims to develop innovative therapeutic approaches to address this significant medical challenge affecting military personnel. As a prominent academic...
The University of Texas at Dallas was awarded a $156,000 Project Grant from the Defense Health Agency under the Military Medical Research and Development federal grant program (CFDA 12.420). The grant will fund research from March 1, 2023 to February 28, 2025 to develop noninvasive diagnostic imaging techniques for aberrant sarcosine biochemistry in prostate cancer. The Military Medical Research and Development program supports basic, applied, and advanced biomedical research with the goals of...
This federal Project Grant award from the Defense Health Agency's Military Medical Research and Development program (CFDA 12.420) provides $909,532.00 to The University of Texas Southwestern Medical Center to conduct research on validating a nonopioid analgesic pathway in human sensory ganglia and spinal cord. The award has a performance period from September 15, 2024 to September 14, 2025. The research aims to explore innovative, non-opioid based approaches to pain management, which is a...
The University of Texas at Dallas (UTD) was awarded a $2,744,321 Project Grant from the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420) to develop a culturally and linguistically sensitive intervention to alleviate core social challenges for young Hispanic autistic children. The award spans the period from September 1, 2024 to August 31, 2028. The project aims to meet the needs of this targeted population by creating an evidence-based...
The University of Texas at Dallas (UTD) was awarded a $1,408,286 federal Project Grant by the Defense Health Agency (DHA) under the Military Medical Research and Development (CFDA 12.420) program. The grant, titled "Effectiveness of an Individualized Progressive Treatment for Expanding Sound Tolerance in Adults with Autism Spectrum Disorder: A Crossover Randomized Controlled Trial (RCT)", aims to conduct advanced biomedical research to develop innovative treatments for individuals with...
This Project Grant award from the Defense Health Agency's Military Medical Research and Development program (CFDA 12.420) provides $234,000.00 to the University of Texas at Dallas (UTD) to conduct in vivo hyperpolarized MRI research on abnormal metabolism in prostate cancer. The award period runs from September 1, 2025 to August 31, 2027. UTD, a prominent public research university, will leverage its expertise in biomedical research, materials science, and advanced technology development to...
This $1,394,919 Project Grant award from the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420) supports the development of nonopioid analgesics to treat chronic pain. The University of Texas Health Science Center at San Antonio (UTHSCSA), a state-controlled research institution, is the prime grantee and will conduct this 3-year research project from August 2024 to July 2027. As a leading academic medical center, UTHSCSA will leverage its expertise in...
The University of Texas Southwestern Medical Center was awarded a $2,641,871 Project Grant from the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420). The grant will fund research from May 1, 2023 through April 30, 2027 to comprehensively upregulate and stabilize frataxin mRNA using antisense oligonucleotides. The goal of this research is to transform health care for service members and the public by investigating medical solutions for the...
The Defense Health Agency awarded a $725,000 project grant to The University of Texas Southwestern Medical Center in Dallas, Texas, for research under the Military Medical Research and Development program. The three-year award beginning June 15, 2023, will support research into glutamine-targeted therapies to prevent traumatic heterotopic ossification. As the parent organization, the University of Texas System will provide research support services through this subaward. The Military Medical...
The University of Texas at Dallas (UTD) received a $183,000 Project Grant award from the U.S. Army Research, Development and Engineering Command (RDECOM) under the Basic Scientific Research program (CFDA 12.431). The funding supports UTD's research on the dynamic mechanical analysis of 3D printable thermoset polymers and composites for defense applications. This foundational research aims to advance the understanding of material properties and performance to support the development of new...